These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
402 related articles for article (PubMed ID: 32306836)
1. Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. Boopathi S; Poma AB; Kolandaivel P J Biomol Struct Dyn; 2021 Jun; 39(9):3409-3418. PubMed ID: 32306836 [TBL] [Abstract][Full Text] [Related]
2. Molecular scaffolds from mother nature as possible lead compounds in drug design and discovery against coronaviruses: A landscape analysis of published literature and molecular docking studies. Khursheed A; Jain V; Rasool A; Rather MA; Malik NA; Shalla AH Microb Pathog; 2021 Aug; 157():104933. PubMed ID: 33984466 [TBL] [Abstract][Full Text] [Related]
3. Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening. Chtita S; Belhassan A; Aouidate A; Belaidi S; Bouachrine M; Lakhlifi T Comb Chem High Throughput Screen; 2021; 24(3):441-454. PubMed ID: 32748740 [TBL] [Abstract][Full Text] [Related]
4. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing. Kumar Y; Singh H; Patel CN J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274 [TBL] [Abstract][Full Text] [Related]
5. A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor. Souza PFN; Lopes FES; Amaral JL; Freitas CDT; Oliveira JTA Int J Biol Macromol; 2020 Dec; 164():66-76. PubMed ID: 32693122 [TBL] [Abstract][Full Text] [Related]
6. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome. van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H Elife; 2020 Apr; 9():. PubMed ID: 32338605 [TBL] [Abstract][Full Text] [Related]
7. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL Froggatt HM; Heaton BE; Heaton NS J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534 [TBL] [Abstract][Full Text] [Related]
8. Coronavirus diseases and pregnancy: COVID-19,SARS, and MERS. Fathi M; Vakili K; Deravi N; Yaghoobpoor S; Ahsan E; Mokhtari M; Moshfeghi M; Vaezjalali M Przegl Epidemiol; 2020; 74(2):276-289. PubMed ID: 33112124 [TBL] [Abstract][Full Text] [Related]
9. Human and novel coronavirus infections in children: a review. Rajapakse N; Dixit D Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199 [TBL] [Abstract][Full Text] [Related]
10. The private versus public contribution to the biomedical literature during the COVID-19, Ebola, H1N1, and Zika public health emergencies. Beall RF; Moradpour J; Hollis A PLoS One; 2021; 16(10):e0258013. PubMed ID: 34679120 [TBL] [Abstract][Full Text] [Related]
14. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection. Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306 [TBL] [Abstract][Full Text] [Related]
15. Computational identification of repurposed drugs against viruses causing epidemics and pandemics via drug-target network analysis. Rajput A; Thakur A; Rastogi A; Choudhury S; Kumar M Comput Biol Med; 2021 Sep; 136():104677. PubMed ID: 34332351 [TBL] [Abstract][Full Text] [Related]
16. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario. Gudadappanavar AM; Benni J J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964 [TBL] [Abstract][Full Text] [Related]
17. Drug Discovery Strategies for SARS-CoV-2. Shyr ZA; Gorshkov K; Chen CZ; Zheng W J Pharmacol Exp Ther; 2020 Oct; 375(1):127-138. PubMed ID: 32723801 [TBL] [Abstract][Full Text] [Related]
18. [Umifenovir and coronavirus infections: a review of research results and clinical practice]. Leneva IA; Pshenichnaya NY; Bulgakova VA Ter Arkh; 2020 Dec; 92(11):91-97. PubMed ID: 33720612 [TBL] [Abstract][Full Text] [Related]
19. In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus. Eleftheriou P; Amanatidou D; Petrou A; Geronikaki A Molecules; 2020 May; 25(11):. PubMed ID: 32485894 [TBL] [Abstract][Full Text] [Related]
20. The Coronavirus Pandemic: What Does the Evidence Show? Paudel S; Dangal G; Chalise A; Bhandari TR; Dangal O J Nepal Health Res Counc; 2020 Apr; 18(1):1-9. PubMed ID: 32335585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]